“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Risk factors, diagnosis and management of (azole-resistant) invasive aspergillosis

€3.03

SKU: product-article-40925 Category: General

Description
Reviews (0)

Description

Risk factors, diagnosis and management of (azole-resistant) invasive aspergillosis

Reviews

There are no reviews yet.

Be the first to review “Article: Risk factors, diagnosis and management of (azole-resistant) invasive aspergillosis”

You must be logged in to post a review.

Top

Article: Risk factors, diagnosis and management of (azole-resistant) invasive aspergillosis

Description

Reviews

Related products

1 year subscription print edition of the Belgian Journal of Hematology (BJH)

Article: Calendar of events

Article: Highlights in respiratory oncology

Article: Highlights in squamous cell carcinoma of the head and neck